Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease

AIMS: Metabolic dysfunction-associated fatty liver disease (MAFLD) is a new nomenclature for nonalcoholic fatty liver. Along with obesity, fatty liver associated with metabolic dysfunction is increasing and has become a serious socioeconomic problem. Non-invasive testing for the confirmation of MAFL...

Descripción completa

Detalles Bibliográficos
Autor principal: Han, A Lum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939216/
https://www.ncbi.nlm.nih.gov/pubmed/35317824
http://dx.doi.org/10.1186/s13098-022-00811-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939216/
https://www.ncbi.nlm.nih.gov/pubmed/35317824
http://dx.doi.org/10.1186/s13098-022-00811-2

Ejemplares similares